Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Riamet tablets
0504010AABBAAAA
|
Riamet | Artemether with lumefantrine | Infections | 1 |
|
Rimactane 300mg capsules
0501090R0BCABAB
|
Rimactane | Rifampicin | Infections | 1 |
|
Rocephin 250mg powder for solution for injection vials
0501021G0BBAAAB
|
Rocephin | Ceftriaxone sodium | Infections | 1 |
|
Stribild 150mg/150mg/200mg/245mg tablets
050301000BBACA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 1 |
|
Terbinafine 62.5mg/5ml oral liquid
0502050C0AAADAD
|
Terbinafine hydrochloride (Systemic) | Terbinafine hydrochloride | Infections | 1 |
|
Tetracycline 250mg capsules
0501030V0AAAAAA
|
Tetracycline (Systemic) | Tetracycline | Infections | 1 |
|
Trimethoprim 200mg/5ml oral liquid
0501080W0AAAMAM
|
Trimethoprim | Trimethoprim | Infections | 1 |
|
Trimogal 100mg tablets
0501080W0BHAAAD
|
Trimogal | Trimethoprim | Infections | 1 |
|
Valcyte 450mg tablets
0503022B0BBAAAA
|
Valcyte | Valganciclovir hydrochloride | Infections | 1 |
|
Valcyte 50mg/ml oral solution
0503022B0BBABAD
|
Valcyte | Valganciclovir hydrochloride | Infections | 1 |
|
Voriconazole 200mg/5ml oral suspension
0502010D0AAADAD
|
Voriconazole | Voriconazole | Infections | 1 |
|
Zidovudine 100mg capsules
0503010Y0AAAAAA
|
Zidovudine | Zidovudine | Infections | 1 |
|
Zidovudine 250mg capsules
0503010Y0AAABAB
|
Zidovudine | Zidovudine | Infections | 1 |
|
Zyvox 600mg tablets
0501070W0BBAAAA
|
Zyvox | Linezolid | Infections | 1 |
|
Abacavir 20mg/ml oral solution sugar free
0503010E0AAABAB
|
Abacavir | Abacavir | Infections | No data available |
|
Abacavir 300mg / Lamivudine 150mg / Zidovudine 300mg tablets
0503010F0AAAAAA
|
Abacavir/lamivudine/zidovudine | Abacavir/lamivudine/zidovudine | Infections | No data available |
|
Achromycin 250mg capsules
0501030V0BBAAAA
|
Achromycin (Systemic) | Tetracycline | Infections | No data available |
|
Aciclovir 1g/40ml solution for infusion vials
0503021C0AAAKAK
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Aciclovir 250mg powder for solution for infusion vials
0503021B0AAAAAA
|
Aciclovir sodium | Aciclovir sodium | Infections | No data available |
|
Aciclovir 250mg/10ml solution for infusion vials
0503021C0AAAIAI
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Aciclovir 500mg powder for solution for infusion vials
0503021B0AAABAB
|
Aciclovir sodium | Aciclovir sodium | Infections | No data available |
|
Aciclovir 500mg/20ml solution for infusion vials
0503021C0AAAJAJ
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Acnamino MR 100mg capsules (Almus)
0501030P0BHABAC
|
Acnamino | Minocycline hydrochloride | Infections | No data available |
|
Agenerase 150mg capsules
0503010I0BBAAAA
|
Agenerase | Amprenavir | Infections | No data available |
|
Agenerase 15mg/ml oral solution
0503010I0BBACAC
|
Agenerase | Amprenavir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.